World

Border restrictions eased in Australian states despite COVID-19 cases surge

Oct 06, 2021

Sydney (Australia), October 6: The border restrictions between Australia's Victoria, Australian Capital Territory (ACT), and New South Wales (NSW) will be eased, as the "relative risks" change in Victoria amid the worsening COVID-19 situation.
From midnight Wednesday, non-lockdown areas of NSW and ACT will change from red to orange zones, and extreme risk zones will move to red zones. Residents entering Victoria from those areas will need to have a test after arriving and wait for a negative result prior to moving into the community.
"As the relative risks change and as we move progressively towards opening up of the Victorian community under the national plan... we will continue to monitor and as we are confident the risk continues to be mitigated in NSW. We want to make sure that we continue to keep a close eye on that and if there are further changes to be made in due course, we will, let everybody know," the Victorian Health Minister Martin Foley said.
The decision came after Victoria recorded its seventh day of recording more than 1,000 COVID-19 daily cases and 11 new deaths, while Australia hits its 80 percent first dose target for all Australians aged over 16.
In the neighboring state of NSW, the COVID-19 cases drop below 600 and the full vaccination rate is about to hit 70 percent in the state.
The NSW Health Department also reported 10 deaths.
Source: Xinhua

More news

Nysh.in Introduces BluHeat Pain Relief Patches: Your Solution to Back Pain Woes!

Mumbai (Maharashtra) [India], April 19: Nysh.in, a trusted and leading provider of effective pain relief innovations, proudly announces the launch of its latest product - BluHeat Pain Relief Patches for back pain. Designed to address the needs of working professionals and home makers alike, who often endure back pain due to long hours of sitting or standing with poor posture, BluHeat Pain Relief Patches offer a natural, chemical-free solution that is trusted and certified for its efficacy.

Apr 19, 2024